NCT03815929View on ClinicalTrials.gov

Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women

PHASE2CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

March 15, 2019

Primary Completion Date

August 28, 2023

Study Completion Date

August 28, 2023

Conditions

Cardiovascular Risk Reduction

Interventions

DRUG

Estradiol 100 Micrograms Patch

Standard

DRUG

Estradiol Patch

Individualized

Trial Locations (1)

55902

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER